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Abstract 
Previous work has shown that exposure to bisphenol A (BPA) during early 
development can affect behavior and sexual differentiation of the brain in rodents, 
although few studies have examined effects on cognitive behavior and associated areas 
of the brain. The current study examined if exposure to BPA during early development 
alters general measures of growth and development, cognitive behavior, and anatomy 
of medial prefrontal cortex (mPFC) in adulthood.  Long-Evans hooded rats were orally 
exposed to corn oil (vehicle), 4µg/kg, 40µg/kg, or 400µg/kg throughout pregnancy and 
during the early postnatal period.  Measures of general growth and development, such 
as body weight, puberty onset, and levels of thyroxine (T4) were assessed at weaning 
age.  One male and one female from each litter were trained on the 17-arm radial arm 
maze in adulthood.  Several weeks following completion of training, brains were 
removed from these rats to stereologically assess neuron and glia number in the medial 
prefrontal cortex.   
Results indicated that levels of T4 at weaning age were significantly altered by 
exposure to BPA.  Additionally, there were also minor indications for learning 
impairments in the radial arm maze task in males, although these were only seen in late 
in training and most comparisons revealed only non-significant trends.  For 
neuroanatomical measures, males exposed to 400ug/kg/day BPA displayed a 
significantly larger number of neurons and glia in layers 5-6 of the mPFC.  In 
conclusion, exposure to BPA leads to alterations in T4 levels at weaning age and 
significant changes in anatomy of the prefrontal cortex in males only.  The changes in 
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neuroanatomy of the prefrontal cortex may be indicative of a particular susceptibility of 
males to exposure of BPA. 
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Chapter 1: 
Background and Significance 
 
Sources of and Exposure to Bisphenol A in Humans 
Bisphenol A (BPA), an endocrine disruptor, is a chemical used in the production 
of many products including polycarbonate plastics (Biles et al., 1997; Krishnan et al., 
1993), resins used to line cans (Brotons et al., 1995), thermal or recycled paper 
(Biedermann et al., 2010; Ozaki et al., 2004), and certain sealants used in dentistry 
(Olea et al., 1996).  It is estimated that global production of BPA exceeds 6 billion 
pounds of BPA annually and it is expected that this amount will only increase in the 
coming years (Burridge, 2003).  According to the recent National Health and Nutrition 
Examination Survey, approximately 93% of the human population shows detectable 
amounts of BPA in urine (Calafat et al., 2008). 
Amid growing concerns of the potential of BPA to disrupt various aspects of 
anatomy, physiology, and behavior, Canada was the first country to declare BPA as a 
toxic chemical in 2008.  In this same year, U.S. retailers of water and baby bottles 
began to remove products that contain BPA from their shelves.  However, the European 
Food Safety Authority and the U.S. Food and Drug Administration (FDA) and 
Environmental Protection Agency (EPA) still consider exposure to BPA at levels 
estimated to occur in humans as safe.  The current “safe” reference dose of BPA 
adopted by both the EPA and FDA is 50µg/kg/day.  This reference dose is based on 
carcinogenesis studies conducted in the 1980s in which 50mg/kg/day was the lowest 
observed adverse effect level for decreases in body weights in adult animals given diets 
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that contained BPA (NTP, 1982; reviewed in Vogel et al., 2009).  Then, 50mg/kg/day 
was divided by 1000 (used as an uncertainty factor) in order to obtain the 50µg/kg/day 
“safe” reference dose that is still used as the standard by U.S. federal agencies today. 
There are significant problems with both the data used to estimate the “safe” 
dose and the conclusions that are drawn from these data.  First, the original study used 
to determine 50µg/kg/day as the “safe” dose was concluded in 1977 by a private 
company which was later investigated for poor quality-control and pathological 
practices.  The committee that was appointed by the U.S. Congress to investigate these 
problems concluded that these issues could have affected the outcomes of any 
research, including the BPA carcinogenesis studies that occurred prior to the 
investigation (Hart, 1979).  Second, the current “safe” dose is not based on empirical 
evidence of low dose studies (i.e. those that occur in the human population), but is 
derived from studies investigating extremely high doses and using the results of one 
particular end point (which was body weight).  Lastly, this conclusion is based on 
information obtained only in adult animals and did not address the potential of BPA to 
produce effects when given to animals undergoing significant developmental changes.  
Of great concern is the fact that BPA has been shown to exhibit nonmotonic dose 
response curves in both in vitro and in vivo models in rodents (see Vanderberg et al., 
2009).  Therefore, low doses, or those seen in human exposure, may be hazardous to 
human health, contrary to the “safe” dose currently accepted by the U.S. FDA and EPA. 
Although human exposure to BPA is thought to mainly occur through leaching 
from products used for food packaging, such as polycarbonate plastics and epoxy 
resins, the use of BPA in other human-use products is widespread.  BPA has been 
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detected in a vast array of human biological tissues including, but not limited to, 
maternal blood, maternal urine, neonatal blood, placenta, cord blood, amniotic fluid, and 
breast milk (Vandenberg et al., 2007; 2010).  Exposures to BPA in the population are 
likely to vary, depending on variations in lifestyle, such as occupation, personal habits, 
and age.  Additionally, estimates of human exposure are also variable depending on the 
method for determination.  Taking into account various data from sources of BPA (food, 
water, soil, and air), Kang et al. (2006) estimated intake of BPA to be less than 
1µg/kg/day, while the European Food Safety Authority (EFSA, 2006) estimates 
exposure to be approximately 1.5µg/kg/day in adults and 0.2-13µg/kg/day in infants and 
children just from food sources alone.  A study conducted in the United States in 2005-
2006 estimated daily intake of BPA based on levels of measured urinary BPA (parent 
BPA + metabolites) to average around 34ng/kg/day, although children under 6 years of 
age exhibit higher levels than adults (Lakind & Naiman, 2011).  Another approximation 
of exposures in humans suggested that New Zealanders may be exposed to as much 
as 4.8µg/day of BPA from food/dietary sources alone (Thomson et al., 2003).  
Therefore, it is conclusively established that the general population is exposed to BPA, 
although the specific range of exposure has been highly debated.   
Although estimates in the normal population are well below the current “safe” 
dose used by the FDA and EPA, most of these estimates do not account for exposure 
from known sources of BPA other than those associated with food consumption.   BPA 
is also transmitted through a transdermal route (Zalko et al., 2011), and it has been 
estimated that individuals who daily handle thermal paper receipts, such as cashiers, 
may be exposed to levels up to 71µg/day, which is significantly greater than those 
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estimated to occur in normal population (Biedermann et al., 2010; Braun et al., 2011).  
U.S. powder paint workers may be exposed to as much as 100µg/kg/day (NTP, 2008; 
Chapin et al., 2008).  Even more alarming is a recent study that found that infants in the 
intensive care unit are exposed to higher than normal and varied levels of BPA most 
likely through the use of medical devices (Calafat et al., 2009).  Certain personal 
practices, such as heating plastics or exposing plastics to high pH environments, can 
increase the amount of BPA that leaches from containers into food and water (Brede et 
al., 2003; Krishnan et al., 1993).  Lastly, it is also important to note that exposure to 
BPA is likely increasing, given that the levels of BPA in human urine doubled overall 
and tripled in the 95th percentile between 1994 and 2004 surveys (NHANES III, 1994; 
NHANES, 2004). 
 It is undeniable that further human studies are needed to clarify not only the 
exposure to BPA in different populations, but also the potential of this chemical to 
disrupt anatomy, physiology, and behavior.  However, several limitations of human and 
epidemiologic studies must be addressed.  First, humans are highly likely to be exposed 
to a wide variety of other endocrine disruptors, such as phthalates, which may confound 
results and make it difficult to decipher the specific effects of BPA.  Additionally, human 
studies allow for correlational information about specific toxicants and changes in the 
brain and behavior, but make it difficult to test direct effects of chemical exposures.  For 
these reasons, it is important to investigate the potential low-dose effects of BPA in 
animal models, where outside exposure can be better controlled and specific 
mechanisms that may influence cognition and behavior, such as changes in brain 
anatomy, can be assessed. 
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Metabolism of BPA 
One important factor in assessing human exposure to potential toxicants is 
metabolism and pharmacokinetics, which lends insight into how often and to what 
extent the human population is exposed.  However, due to difficulty of assessing 
metabolism of BPA in humans, most of this work has employed rodent or non-human 
primate models.  One study has suggested that the route of exposure of BPA is likely to 
have a large impact on metabolism (Pottenger et al., 2000), given that oral exposure 
would be susceptible to first pass metabolism while other routes, such as subcutaneous 
injection or transdermal exposure, would not.  However, more recent evidence suggests 
that the impact of route of exposure is dependent on the age of the animal model.  
Doerge et al., (2011) demonstrated that PND 3 mice showed similar levels of the 
unconjugated form when BPA was given subcutaneously or orally through gavage.  
However, differences were seen between the two different exposures when PND 10 or 
older mice were examined.  The authors pointed out that these age-specific effects are 
most likely due to an underdeveloped liver in the early postnatal life of mice that does 
not occur during the late fetal stage in non-human primates (Doerge et al., 2011; 
Doerge et al., 2010a; 2010b).   
These species comparisons have led to discussion about the species specificity 
of metabolism of BPA.  The fact that metabolism of BPA in  perinatal rodents is different 
than that of the fetal monkey after administration of BPA by intravenous injection has 
led to discussions that the rodent model may not always represent the best model for 
human exposure to BPA.  While it has been suggested that adult non-human primates 
and rodents metabolize BPA in a similar manner (Doerge et al., 2011; Taylor et al., 
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2008), there may be metabolic differences between species during the fetal age.  
However, as levels of unconjugated BPA in serum were not reported in non-human 
primate fetuses after oral dosing (Doerge et al., 2010b) even though they were reported 
during early postnatal mice and rats (Doerge et al., 2010a; 2011), it is difficult to make 
direct comparisons with respect to oral dosing between these different studies. 
Liver metabolism of BPA is accomplished mainly through glucuronidation by 
UDP-glucuronosyltransferase, and BPA-glucuronide has been identified as the major 
metabolite in humans and rodents (Snyder et al., 2000; Kurebayashi et al., 2003; 2010; 
Völkel et al., 2002).  BPA-glucuronide has been shown to have little or no estrogenic 
activity in vitro (Matthews et al., 2001), although it has been suggested that other 
metabolites of BPA, such as MBP, may bind estrogen receptors more potently than the 
parent compound (Ishibashi et al., 2005; Yoshihara et al., 2004).  Parent BPA is mainly 
excreted through the feces, while the main metabolite, BPA-glucuronide, is excreted 
primarily through urine (Synder et al., 2000, Pottenger et al, 2000). 
Several human studies have reported a fast metabolism of BPA, with a half life, 
as detected in urine, of between 4-5.5 hours after oral exposure (Völkel et al., 2002; 
2005).  Based on this information, it is generally concluded that the entire process is 
complete within 24 hours, making it likely that estimated exposures in humans are a 
result of persistent exposure to the chemical.  However, more recent data suggest that 
human BPA-glucuronide levels did not decline rapidly after significant fasting, potentially 
because significant exposure to BPA is occurring either from non-food sources or is 
accumulating in other tissues, such as fat (Stahlhut et al., 2009).  In rodents, a recent 
study examined metabolism and time courses after oral administration and found that 
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peak values in plasma are reached between 15-45 minutes after ingestion of BPA 
(Domoradzki et al., 2004).  A second peak of BPA was noted at about 24 hours and 
levels were still quantifiable after 96 hours.  Although it is possible that BPA persists 
longer than expected as based on levels of metabolites of BPA in human urine, the 
demonstrated short half life of this chemical along with the pervasive use of BPA in 
human-use products suggests that human exposure is likely occurring on a persistent 
and daily basis. 
Hormonal Mechanisms of BPA 
BPA belongs a group of chemicals that are often referred to as endocrine 
disruptors, primarily based their ability to bind to estrogen receptors.  This action of BPA 
has been proposed as the mechanism by which BPA may exert effects on reproduction, 
brain anatomy, and brain function.  Many past studies have therefore used estradiol or 
an estrogen receptor agonist to serve as a positive control.  As assessed in animal 
models, BPA’s affinity for estrogen receptor α (ERα) and estrogen receptor β (ERβ) is 
1,000-10,000 fold less than estradiol (Gould et al., 1998; Kuiper et al., 1998), and it 
binds ERβ with a higher affinity than ERα (Kuiper et al., 1997; Matthews et al., 2001; 
Routledge et al., 2000).  One report suggests that in some cell types, BPA may exert 
mixed agonist and antagonist activity through ERβ (Kurosawa et al., 2002).  Some of 
the initial lack of concern by certain governmental agencies for BPA exposures at 
human relevant doses grows from the past evidence that BPA is a very weak agonist at 
estrogen receptors.  However, more recent reports suggest that BPA also binds to non-
classical membrane estrogen receptors and G-protein coupled receptors (such as 
GPR30) and has actions through non-genomic pathways (Alonso-Magdalena et al., 
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2005; 2011; Zsarnovszky et al., 2005; Watson et al., 2005; Thomas & Dong, 2006; 
Ropero et al., 2006).  Furthermore, BPA likely alters expression of classical estrogen 
receptors in the brain.  Alterations in levels of ERα and ERβ expression (Ramos et al., 
2003; Cao et al., 2012), ESR1 and ESR2 mRNA expression (Khurana et al., 2000; 
Kawai et al., 2007; Cao et al., 2013), and the number of ER-labeled neurons (Ceccarelli 
et al., 2007) have all been reported in rodent models, although the magnitude and 
direction of effects are specific to particular brain areas.  
In addition to effects relating to estrogen and estrogen receptors, BPA binds to or 
alters other hormone systems (see Rubin et al., 2011).  The most studied of these is 
thyroid hormone.  BPA antagonizes thyroid hormone receptors, although the affinity is 
lower than that for estrogen receptors (Moriyama et al., 2002; Zoeller et al., 2005).  
Gestational and lactational exposure to BPA also increases levels of thyroxine and 
expression of thyroid responsive genes in the brain during early postnatal development 
in rodents (Zoeller et al., 2005).  Furthermore, BPA given during gestation and early 
postnatal development resulted in a transient hyperthyroidism in a lower dose of BPA 
(at postnatal day 7) and hypothyroidism in a higher dose of BPA (at postnatal day 21) in 
male offspring, while no effects were seen in female offspring (Xu et al., 2007).   
Estrogen related receptor gamma (ERRγ) is another receptor to which BPA binds 
with a relatively high affinity (Matsushima et al., 2008; Okada et al, 2008).  Importantly, 
there is high expression of ERRγ in the placenta, potentially contributing to 
accumulation of BPA in the placenta and effects of BPA on early development (Takeda 
et al., 2009; Arase et al., 2011).  Lastly, androgen receptors are another potential target 
of BPA.  Several in vitro studies suggest that BPA has antiandrogenic activities (Sohoni 
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& Sumpter, 1998; Lee et al., 2003; Sun et al., 2006; Kruger et al., 2008), and in addition 
can inhibit aromatase (Bonefeld-Jorgensen et al., 2007), an enzyme that mediates the 
conversion of testosterone to estrogen. 
Increased Susceptibility to BPA During Early Development 
Although the majority of the human population is exposed to BPA, particular 
concern has arisen regarding the potential effects of exposure to BPA during early 
development. The fetus and neonate are normally protected from the impacts of 
estrogens by α-fetal protein, which prevents estradiol from passing through the 
placenta.  However, it is thought that BPA binds serum proteins with limited capacity 
compared to other estrogens (Milligan et al., 1998).  Elevated levels of BPA metabolites 
have been reported in women who are pregnant, compared with their pre-pregnancy 
levels (Braun et al., 2012).  Also, BPA readily passes through the placenta, mostly in its 
active unconjugated form (Balakrishnan et al., 2010).  Therefore, the fetus and neonate 
may be particularly susceptible to being exposed to parent BPA.  Past investigations 
that assess levels of BPA in maternal compared to fetal tissues also support the idea 
that the fetus is exposed to BPA.  In humans, levels of BPA detected in the amniotic 
fluid were approximately 5 times higher than those reported in other fluids, such as the 
serum from pregnant women (Ikezuki et al., 2002).  Additionally, median levels of BPA 
were 3.1ng/ml in maternal plasma, 2.3ng/ml in fetal plasma, and 12.7ng/g in placental 
tissue (Schönfelder et al., 2002).  In rodents, BPA was administered to pregnant 
females and was detected in rodent fetal tissue at levels greater than those detected in 
maternal blood, and BPA was still detectable up to 50 hours after exposure, the time at 
which the measurement was terminated (Takahashi & Oishi, 2000).  BPA is found in 
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higher concentrations in the mouse fetus and amniotic fluid than in maternal blood 
during maternal exposure of BPA (Zalko et al., 2003).  Therefore, BPA is likely passed 
from the mother to the developing fetus in both humans and rodents. 
While much of the previous information on the metabolism of BPA discussed in 
the preceding section explained general metabolism of BPA, differences in metabolism 
during pregnancy or within the developing fetus are of particular concern.  A recent 
relevant study found that the fetal liver has no UDP-glucuronosyltransferase activities, 
leading to the conclusion that the fetal rat is unable to metabolize BPA in the same way 
as adults (Matsumoto et al., 2002).  The same study reported that rat hepatic 
microsomal UDP-glucuronosyltransferase activities were decreased 2 fold in pregnant 
rats.  Therefore, exposure to parent BPA is likely higher in the fetus than previously 
thought due to the fact that a significant amount of the studies that assess metabolism 
of BPA are based solely in non-pregnant adult rats. 
Effects of BPA Sexual Behavior and Reproduction 
 Some research regarding BPA has focused on effects on reproduction and 
reproductive tissues.  There has been evidence that BPA, at certain doses, alters 
aspects of sexual behavior in male rodents.  For example, sexually experienced males 
exposed to 50µg/kg/day had decreased number of intromissions and copulatory 
efficiency (# of intromissions/# of mounts) and increased ejaculation latency compared 
to controls (Jones et al., 2011).  Interestingly, neither 5µg/kg/day nor 500µg/kg/day 
significantly altered these sexual behaviors and in fact, those given 5mg/kg/day actually 
displayed enhanced sexual behavior, as evident by decreased post-ejaculatory, mount, 
and intromission intervals in a sexually inexperienced condition.  In addition, almost all 
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aspects of male sexual behavior examined in this study (Jones et al., 2011) showed 
nonmotonic dose response curves with respect to BPA.  In another study examining 
male sexual behavior and using only one dose of BPA (40µg/kg/day), males were 
impaired in both the intromission latency and number of intromissions (Farabollini et al., 
2002).  Studies assessing sexual behavior in females have reported mixed findings, 
with evidence for impaired (Monje et al., 2009), enhanced (Jones et al., 2011; 
Farabollini et al., 2002), or unaffected (Ryan et al., 2010; Adewale et al., 2009) 
receptive or proceptive behaviors.  
 Various measures of reproductive function in females and males suggest a 
susceptibility to BPA during early development (for review see Salian et al., 2011; 
Richter et al., 2007).  For instance, fecundity may be impaired in females exposed 
during gestation and lactation, as demonstrated in a forced breeding experiment in 
which the cumulative number of pups was decreased in groups receiving either 
25ng/kg/day or 25µg/kg/day, and the total number of litters was decreased in the group 
receiving 25µg/kg/day (Cabaton et al., 2010).  Extensive evidence is available for 
studies in rodents in which changes were detected in the reproductive tract due to BPA 
exposure.  In females, alterations in the anatomy or physiology of the vagina, uterus, 
and ovary have all been reported (Markey et al., 2005; Schönfelder et al., 2002; 2004; 
Nikaido et al., 2004; Peretz et al., 2011).  Although two studies have failed to provide 
any evidence for changes in general fertility in males after developmental BPA exposure 
(Ema et al., 2001; Tyl et al., 2002), it is highly probable that BPA may affect 
reproductive measures such as spermatogenesis, sperm motility, and sperm 
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morphology (Salian et al., 2009; Toyama et al., 2004; Toyama & Yuasa, 2004; Aikawa 
et al., 2004).   
Effects of BPA on the Brain and Behavior 
 Currently, one of the largest concerns for BPA exposure during development is 
its impacts on the brain and behavior.  Long-lasting changes due to early exposure of 
BPA have been noted in a variety of tasks including those that measure anxiety, sexual, 
learning and memory, and social behavior.  In addition, changes in the development of 
brain areas associated with reproductive and cognitive abilities have been found with 
respect to BPA.  A number of recent papers have reviewed both behavioral and neural 
evidence for developmental disruption induced by BPA (Hajszan & Leranth, 2010; Itoh 
et al., 2012; Richter et al., 2007; Welshons et al., 2006; Wolstenholme et al., 2011; 
Golub et al., 2010).  Given the coordination that must occur during this time period for 
correct formation of both cells in the nervous system and connections between different 
brain areas, it is possible that a chemical, such as BPA, would induce long-lasting 
changes in the brain.  Further discussion centering on the previously demonstrated 
effects of BPA on brain and behavior is presented in the following chapters.  
General Rationale and Aims for Current Studies 
 The following completed studies aim to clarify whether BPA exposure during 
gestation and early postnatal development alters cognitive behavior and anatomy of the 
prefrontal cortex in adulthood.  In order to mimic human exposure in utero, pregnant 
rats received oral administration of various low doses of BPA (0, 4, 40, or 400ug/kg/day) 
throughout the entire period of gestation.  Importantly, several papers have suggested 
that exposure of mice to ~400ug/kg/day produces 24‑hr unconjugated serum BPA 
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levels slightly below the levels that have been demonstrated in human women (Taylor et 
al., 2011, Vandenberg et al., 2010), establishing the highest dose in this study as 
physiologically relevant.  Since rats are born at a premature state compared to humans, 
offspring of the dosed pregnant rats received oral administration of BPA until the 10th 
day after birth.  Adult behavior and anatomy of the prefrontal cortex were assessed to 
determine whether exposure to BPA during early development induces long-lasting 
neural changes. 
 The second chapter focuses on whether administration of BPA during 
development induces changes in puberty onset, body weight, liver weight, brain weight, 
and levels of thyroxine (T4).  Changes in puberty onset and body weight have been a 
particular concern to toxicologists given that human females are trending towards earlier 
onset of puberty and that obesity and body-weight associated diseases, such as 
diabetes, have been increasing drastically within the last few decades.  Estimates 
suggest that these trends are likely to persist in the future.  Attainment of these various 
endpoints allows for a more comprehensive view of the potential effects of BPA.  They 
also add to the current available research regarding BPA, given that several other 
studies have examined the same endpoints.   
The third chapter focuses on behavioral changes associated with BPA.  Rats 
exposed to BPA during early development were trained in adulthood on the 17-arm 
radial maze with both baited and unbaited arms, a challenging task that has yet to be 
examined with respect to BPA.  This task allows for a more detailed view of effects 
compared to other behavioral tasks, given that both working and reference memory 
errors are analyzed.  Also, the increased difficulty of this task compared with other 
  
 
14 
 
cognitive tasks, such as the water maze, allow for better detection of small changes in 
behavior.  Both males and females were used in this study to determine whether this 
potential toxicant alters sex differences, which have been previously demonstrated in 
this task, and/or whether BPA induces sex-specific alterations.  Long-lasting behavioral 
changes in response to BPA may reflect changes in development of the brain, which is 
the focus of the fourth chapter.  
 Utilizing the same rats that were behaviorally tested, the third and final study 
examined adult neuron and glia number in the medial prefrontal cortex (mPFC), a 
structure that when lesioned, impairs acquisition of the radial arm maze task (Kolb et al., 
1982; Kesner et al., 1987; Joel et al., 1997).  White matter volume was also assessed in 
the area adjacent to the prefrontal cortex.  Assessment of these endpoints converges 
with results of the behavioral study to determine whether changes in the brain are 
concurrent with changes in behavior.   
To conclude, the following studies are designed to help clarify whether doses of 
BPA that correspond to human exposure and are currently considered “safe” by the 
EPA and FDA have long-lasting impacts on the brain and behavior.  The hypothesis is 
that perinatal exposure to BPA would alter learning and sex differences in radial arm 
maze.  Additionally, this endocrine disruptor may also alter normal development of, or 
sex differences in, the prefrontal cortex. 
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Chapter 2: 
Effects of Bisphenol A on Growth and Development 
 
Introduction 
Several emerging concerns pertaining to BPA exposure during early 
development are the potential for this endocrine disruptor to contribute to changes in 
body weight and puberty onset.  Many studies performed with rodents have 
demonstrated increases in body weight in response to low doses of BPA during early 
postnatal development (Rubin et al., 2001), at weaning age (Howdeshell et al., 1999), at 
times corresponding to the onset of puberty (Rubin et al., 2001; Miyawaki et al., 2007), 
and in adulthood (Nikaido et al., 2004; Rubin et al., 2001; Patisaul & Bateman, 2008).  
Interestingly, a recent review highlighted the evidence that these increases in body 
weight are either only visible or are more exaggerated in females than males (Rubin & 
Soto, 2009).  However, there are also a few studies that fail to find significant changes 
or report decreases in body weight (often seen when using doses that exceed those 
expected to occur in humans) after exposure to low dose BPA (Stump et al., 2010; 
Nakamura et al., 2012; Newbold et al., 2007; Tyl et al., 2002; Tyl et al., 2008).  These 
differences in the results of studies are likely due to differences in the dose of BPA, 
dosing duration and method, and the strain of the rat or mouse used to evaluate the 
effects of BPA.  Given that changes in body weight have mainly been demonstrated in 
mice and Sprague Dawley rats, it is important to ascertain whether changes in body 
weight after BPA exposure are also apparent across several different doses and in 
different strains of rats (i.e. Long-Evans).  Long-lasting changes in body weight may be 
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indicative of alterations in adipogenesis or metabolic processes.  Substantial increases 
in obesity have been seen in the human population over the last few decades, and 
these epidemiological changes coincide with our increased use and exposure to BPA.  
Therefore, it is important to use controlled studies in rodents to further evaluate the 
relationship between body weight and BPA exposure. 
Altered puberty onset in females and males is another potential effect of 
developmental exposure to BPA.  Puberty onset in female rats, as assessed by vaginal 
opening, has been examined in several studies.  Honma et al. (2002) reported earlier 
puberty onset in female mice that had been exposed to 20µg/kg/day through 
subcutaneous injections from gestational days 11-17, although no effects were found 
when rats were given 2µg/kg/day.  Additionally, another study reported earlier vaginal 
opening in Long-Evans rats that were injected with 50µg/kg/day (but not 50mg/kg/day) 
from postnatal day 0 to postnatal day 3 (Adewale et al., 2009), which may be due to 
alterations in RFamide-related peptide-3 neurons in the hypothalamus (Losa-Ward et 
al., 2012).  Contrary to these results, several studies have found no effects on vaginal 
opening at oral doses ranging from 2 to 200µg/kg/day during gestation and lactation 
(Tinwell et al., 2002; Ryan et al., 2010; Howdeshell et al., 1999).  In addition to 
accelerated puberty in females demonstrated by changes in vaginal opening, it has also 
been reported in females that BPA during early development increased the age at which 
the first estrus cycle occurred (Howdeshell et al., 1999).  Consequently, these mixed 
results suggest a potential response to BPA and a need for further studies to determine 
whether BPA induces earlier pubertal onset in female rodents.   
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Preputial separation is an external marker of puberty in male rodents.  This 
occurs when the glans penis becomes anatomically disconnected from the prepuce, 
allowing for retraction of the latter (Korenbrot et al., 1977).  To date, several studies 
have examined whether low dose BPA affects preputial separation (Tinwell et al., 2002; 
Kato et al., 2006; Tyl et al., 2002, 2008).  From these studies which used either mice or 
Sprague-Dawley rats, only one that utilized an extremely high dose (100mg/kg/day) 
reported delayed preputial separation.  Therefore, studies using other strains of rats and 
doses that correspond to human exposure are needed.   
Collection of other measures of general growth and development, such as liver 
weight, aids in the determination of whether BPA is a developmental toxicant.  Changes 
in liver weight are often used a marker for general toxicity, in that increases in liver 
weights may be indicative of increases in enzyme induction, hyperplasia, or hypertrophy 
of the liver (Amacher et al., 1998; Williams & Iatropoulos, 2002).  All of these specific 
changes in liver anatomy and function could point to a potential mechanism of 
increased liver metabolism.  To date, no effects on adult liver weight have been 
reported in the few studies that assessed this measure after early developmental 
exposure to BPA in doses at or below 50mg/kg/day (Tinwell et al., 2002; Tyl et al., 
2002; Tyl et al., 2008).   
Changes in litter size, implantation sites, and sex ratio would represent 
alterations to fertility in the dams and can be indicative of general reproductive function.  
Although several studies have reported decreased litter size and implantation sites after 
extremely high doses (>400mg/kg/day), no studies have reported changes due to 
administration of lower doses of BPA (Tyl et al., 2002; Kim et al., 2001; Ema et al., 
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2001; Negishi et al., 2003; Tinwell et al., 2002).  Furthermore, sex ratio, although only 
assessed in handful of studies, is not altered by low or high doses of BPA (Ema et al., 
2001; Negishi et al., 2003; Tinwell et al., 2002).   
Lastly, brain weight is a measure that is designed to give indications on whether 
a toxicant, such as BPA, causes global changes in the brain.  However, changes in 
brain weight could be due to a variety of mechanisms, including but not limited to 
changes in gray or white matter volume, the total number of cells, or increases in 
synapses or dendrites.  To date, no developmental BPA-induced changes in brain 
weight have been reported in doses ranging from 0.2-200µg/kg/day (Ferguson et al., 
2011; Ema et al., 2001). 
In the current study, measures of general growth and development were 
assessed in both the dams and offspring.  Measures in the dam were collected 
immediately following weaning and included body weight, liver weight, brain weight, and 
implantation sites.  In addition, litter size and sex ratio of the litter on postnatal day 1 
were assessed.  Offspring measurements included body weight from PND 1-9, at 
weaning, and in adulthood.  Additionally, adult brain and liver weight, and puberty onset 
were also assessed.  Given that the current “safe” dose is derived from data obtained in 
adult animals, it is important to determine whether BPA given during a proposed critical 
period (gestation and early postnatal development) does, in fact, differ from its effects 
on adults.  If effects are found that are specific to early exposure to BPA, it would 
question the current standard of using adult animals to determine the potential 
toxicology of endocrine disruptors. 
Methods 
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Breeding and Housing Procedures 
Adult (>80 days old) female and male Long Evans rats were obtained from 
Harlan and used as breeders.  Due to the long length of time needed to behaviorally 
test the exposed offspring, two separate cohorts of animals were used. Numbers of 
litters for each treatment are as follows: oil =9, 4µg/kg/day=10, 40µg/kg=13, 
400µg/kg/day=12.  Therefore the sample size was 9-13 litters/treatment group.  
Precautions were undertaken to minimize exposure to materials that might contain BPA 
(recycled paper, polycarbonate plastics, etc.).  All rats in the current study were housed 
in clear, polysulfone cages (except during breeding) and given access to reverse 
osmosis water in glass bottles.  The diet used in this experiment (Harlan 2020X) 
contained low, but stable amounts of phytoestrogens.  Prior to breeding, female 
breeders were pair- or triple-housed, while males were single-housed due to aggressive 
behavior towards cagemates displayed in the first several days after arrival of the 1st 
cohort.   Breeding procedures did not begin until at least 2 weeks after arrival.  During 
the time between arrival and breeding, male and female breeders were handled at least 
3 times, while females received 100µl of tocopherol-stripped corn oil pipetted onto a ½ 
of a cookie (Newman’s Own Arrowroot flavor) after each bout of handling.  For 
breeding, one male and one female were placed in metal breeding cages and were 
monitored daily for the presence of a one sperm plug underneath the corresponding 
cage.  If no sperm plug was detected after 6 nights, a different male was placed with the 
female for an additional 6 nights.  Upon detection of a sperm plug, females were 
removed from breeding cages and were single-housed in polysulfone cages throughout 
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the remainder of the experiment.  Dosing of pregnant dams was initiated on the first day 
of detection of at least one sperm plug. 
Dam Dosing 
During each day of dosing, females were weighed and solutions were mixed 
thoroughly by the use of a stir bar to ensure homogeneity.  BPA powder was suspended 
in tocopherol stripped corn oil to make different solutions (0, 0.01. 0.1, or 1 mg BPA/ml 
oil) and these solutions corresponded to daily doses of 0, 4, 40, or 400µg BPA/kg of 
body weight/day throughout the entire period of pregnancy.  Fresh solutions were 
prepared prior to each cohort of rats.  0.4µl of solution/g of body weight was pipetted on 
a ½ of a cookie (Newman’s Own Arrowroot flavor) and was allowed to dry for several 
minutes before administration to each dam in their home cages.  Dams consumed the 
½ of a cookie within 5 minutes. 
Pup Dosing 
The day of parturition was designated as postnatal day (PND) 0.  Similar to 
dosing of the dams, solutions (0, 0.002, 0.02, and 0.2mg BPA/ml of oil) were mixed 
daily and prepared prior to the start of each cohort.  Direct oral administration of the 
same doses of BPA solutions that were given to dams (0, 4, 40,and 400µg BPA/kg of 
body weight/day) were given to pups beginning the day after birth (PND 1) and 
continued until PND 9.  Although many previous studies relied on lactational transfer of 
BPA from dams to pups as a route of exposure, there has been recent evidence to 
suggest that using this method results in extremely low exposures to the pups (Doerge 
et al., 2010c).  Procedures for this portion of the experiment included placing the dam in 
a separate cage and recording weight and sex for each individual pup.  Pups were then 
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picked up, a pipette was placed in the mouth, and the solution was dispensed.  Pups 
were given 2 separate bouts of oral dosing for a total volume of 2µl solution/g body 
weight.  Body weights were recorded for all offspring at this time, and therefore, results 
for average body weight during early development (PND1-9) were determined by 
calculating the average body weight for females and males separately from each litter.  
Litter size and sex ratio was assessed on PND 1.  At PND 2, litters were culled to a 
maximum of 10 pups, while trying to maintain a balanced sex ratio in each litter as much 
as possible. 
At PND 23, all offspring were weaned and 2 females and 2 males from each litter 
were weighed and retained for future behavioral and neuroanatomical endpoints.  Dams 
and remaining littermates were sacrificed at this time, and various measurements were 
recorded, including body weight, liver weight, brain weight, and implantation sites in the 
dams.  Analyses of offspring body weight at weaning represent an average of all of the 
females and all of the males from each litter.  All rats retained for later measures were 
double-housed with same sex littermates and handled once a week for the remainder of 
the experiment.   
Beginning at PND 25, females were checked daily for vaginal opening, and 
males were visually checked daily for preputial separation beginning on PND 30 to 
determine onset of puberty.  Puberty onset was averaged from the 2 female and 2 male 
offspring from each litter.  Prior to food restriction for behavior in adulthood, weights for 
all rats were recorded around PND 85 and these weights were used for analysis of adult 
body weights.  Ad libitum food was returned immediately upon completion of behavioral 
testing.  Although body weights were also measured prior to sacrifice (PND 140) for the 
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later experiments, these were not analyzed due the variability in time (2-5 weeks) 
between the end of food deprivation used for behavioral training and sacrifice.  At the 
time of sacrifice (around PND 140), liver and brain weights of the offspring were also 
recorded.  These measures taken in adulthood from the offspring (adult body, brain, and 
liver weights) were calculated as an average of the two offspring from each sex that 
were available from each litter.   
T4 Serum Analyses 
 At weaning, trunk blood was collected from littermates that were not used for 
further behavioral and anatomical endpoints.  Serum from a maximum of one female 
and one male from each litter was analyzed for thyroxine levels (T4).  Serum T4 was 
measured by radioimmunoassay based on previously reported methods (Schneider et 
al., 2006; Taylor et al., 2008) from a maximum of one male and one female from each 
litter. 5 µl of serum was assayed per tube and added to 200µl of GAB. The primary 
antibody used was a polyclonal rabbit anti-T4 antibody (Cat#20-TR40, Fitzgerald 
Industries International, Concord, MA). Approximately 0.006 µCi of [125I]-T4 was added 
on the third day. On the fifth day, 50µl of 200µg/ml (10µg) solution of rabbit 
immunoglobulin was added, followed by 100µl of a GAR secondary antibody solution 
(Cat#R0881, Sigma) prepared at 60% of the manufacturers recommended volume for a 
final dilution of approximately 1:8. Tubes were incubated at room temperature for 30 
minutes before addition of 1ml of a 25% wt/vol solution of PBS/PEG. Tubes were then 
centrifuged, aspirated, and counted in a gamma counter.  All samples were run single 
assay. The serum T4 assay had lower and upper limits of detection of 0.05µg/dl and 
10.5µg/dl, respectively for a 5µl sample. The sensitivity of the assay as determined by 3 
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standard deviations from the zero standard and 3 standard deviations from the 
nonspecific binding level.  The coefficient of variation was 8.1%.   
Statistical Analyses 
Measures taken from the dams were analyzed with ANOVAs (SPSS; version 19; 
SPSS Inc., Chicago, IL) with treatment as the independent factor and cohort as a 
covariate.  Statistical significance was set at p<0.05. 
All measures in the exposed offspring were analyzed using ANOVAS with the 
between-subject variable being treatment and using cohort as a covariate.  One way 
ANOVAS were used as posthoc tests in order to include cohort as a covariate.  In cases 
where data was available from more than one littermate per sex, averages were 
calculated for each sex of each litter.  Due to large, well-known sex differences in most 
of the measures, females and males were analyzed separately.  In order to account for 
body weight affecting liver weight, liver weight was divided by body weight measured at 
the time the animals were sacrificed.  Statistical significance was set at p<0.05.   
Results 
Maternal Measures 
Adult female rats that were exposed to BPA during their pregnancy did not 
exhibit any significant differences in body weight, brain weight, liver weight, or number 
of implantation sites (Table 1).  Litter size and sex ratio of the offspring were not 
significantly affected by BPA treatment (Table 1).  Sample sizes for these measures 
were as follows: 0µg/kg = 9, 4µg/kg = 10, 40µg/kg =13, 400µg/kg =12.  The remaining 
results are those obtained from the offspring of these dams. 
Offspring Measures 
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Results for effects of BPA on body weight at early postnatal development, at 
weaning, and in adulthood (PND 85) are shown in Figure 1.  BPA treatment did not 
affect body weight in males or females at any age or in any of the doses examined.  
Additionally, no significant treatment effects in males or females were found in puberty 
onset, adult brain weights, or adult relative liver weights (Table 2).  Sample sizes for 
these measures were as follows: 0µg/kg = 9, 4µg/kg = 10, 40µg/kg =13, 400µg/kg =12.   
 Results for thyroxine levels (T4) are shown in Figure 2. Sample sizes (shown in 
the graphs) for females were 0µg/kg = 8, 4µg/kg = 9, 40µg/kg =11, 400µg/kg =12 and 
for males were 0µg/kg = 9, 4µg/kg = 9, 40µg/kg =11, 400µg/kg =10.  There was a 
significant effect of treatment in T4 levels at weaning in females (p<.05) and a 
nonsignificant trend in males (p=.09).  Analysis of T4 levels between the BPA-treated 
and control animals showed a significant increase in T4 levels in female rats exposed to 
4µg/kg/day compared to both the control group (p<.05) and the group that received 
40µg/kg/day (p<.01).  There was also a strong trend in females towards lower levels of 
T4 in the 40µg/kg/day treatment group compared to the 400µg/kg/day group (p=.06).  In 
males, the 4µg/kg/day group had lower levels of serum T4 than the 40µg/kg/day group 
(p<.05).  These results suggest effects of BPA on T4 levels at weaning represent a non-
monotonic dose response curve. 
Discussion 
The current study found no significant effects of BPA on maternal endpoints or in 
litter size or sex ratio of the litter.  The lack of effects on maternal body weight, litter 
size, and sex ratio are consistent with past studies that used comparable doses of BPA 
(Tinwell et al., 2002; Tyl et al., 2002, 2008; Ema et al., 2001; Somm et al., 2009, 
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Ferguson et al., 2011; Negishi et al., 2003).  Therefore, BPA given during pregnancy 
does not result in changes in general toxicological measures in dams assessed several 
weeks after discontinuation of treatment. 
BPA exposure during early development did not alter body weight, brain weight, 
liver weight, or puberty onset in males and females.  The lack of effect on body weight is 
in contrast with many studies that have demonstrated significant increases in body 
weight after exposure to BPA, especially in females (Howdeshell et al., 1999; Nikaido et 
al., 2004; Rubin et al., 2001; Patisaul & Bateman, 2008; Miyawaki et al., 2007; Somm et 
al., 2009).  However, there is also support for a lack of effects on body weight.  For 
example, other studies have demonstrated either decreases or no significant changes in 
body weight in rodents exposed to BPA during early development (Stump et al., 2010; 
Nakamura et al., 2012; Newbold et al., 2007; Tyl et al., 2002; Tyl et al., 2008; Kobayashi 
et al., 2002).  These differential effects in the response to BPA may be mediated by 
methodological differences between the studies such as diet and the dose of BPA that 
was being tested.  There is also evidence that position of the fetus in the uterus during 
gestation may mediate some of these differences given that females surrounded by 2 
males did not show weight differences at weaning, while females surrounded by 0 or 1 
male exhibited increases (Howdeshell et al., 1999).   
Puberty onset was not significantly affected in either males or females rats 
perinatally exposed to BPA.  In previous studies that investigate effects of BPA at doses 
below 500µg/kg/day, accelerated vaginal opening in females has been reported (Honma 
et al., 2002; Adewale et al., 2009), although there have been several studies that fail to 
find effects on this same measure (Ryan et al., 2010; Tinwell et al., 2002).  The only 
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studies that examined preputial separation after exposure to BPA, at doses comparable 
to the current study, did not find effects on this measure (Ema et al., 2001; Tyl et al., 
2002; Kato et al., 2006; Tyl et al., 2008), which is consistent with the lack of effects 
exhibited in the current study. No effects on relative liver or brain weight were apparent 
in rats that were perinatally exposed to bisphenol A.  These results are consistent with 
past studies that have examined these measures (Tyl et al., 2002; Kobayashi et al., 
2002). 
Despite a lack of changes in most of the measures that are often used to 
determine whether chemicals are potential toxicants, there were significant alterations 
to T4 at weaning.  Importantly, these changes occur are apparent several weeks after 
the discontinuation of treatment.  Given that BPA has a short half life (Völkel et al., 
2002; 2005), it is highly unlikely that BPA is still present in the blood of the offspring, 
suggesting that BPA exposure induced lasting changes in hormone levels.  The finding 
that BPA may alter the thyroid hormone system is not without precedent.  For example, 
BPA antagonizes thyroid hormone receptors and increases expression of thyroid 
responsive genes (Moriyama et al., 2002; Zoeller et al., 2005).  Additionally, maternal 
exposure to 1mg/kg, 10mg/kg and 50mg/kg BPA increased levels of thyroxine in both 
males and females at PND 15, but not at PND 4, PND 8, or PND 35 (Zoeller et al., 
2005).  However, the doses used in this previous study are unlikely to correspond to 
doses of BPA that occur in the human populations.  BPA given during gestation and 
early postnatal development also resulted in a transient hyperthyroidism (at postnatal 
day 7) in a lower dose of BPA and hypothyroidism (at postnatal day 21) in a higher dose 
of BPA in male rat offspring, while no effects were seen in female offspring (Xu et al., 
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2007).  How the doses in Xu et al. (2007) correspond to those used in the current study 
are unknown, given that the BPA administration was given in the water (in mg/L) and 
the amount of water that the dams consumed was not reported.  In conclusion, T4 
levels at weaning are significantly altered after early exposure to BPA.  More studies are 
needed to determine the immediate effects of BPA during dosing and whether changes 
in T4 reported here persist into adulthood. 
To summarize, the results obtained in this study suggest that developmental 
BPA, at levels corresponding to estimated exposures in humans, does not induce 
alterations in measures assessed in the dams.  However there were significant 
alterations to thyroxine levels at weaning, suggesting that current methods (such as 
measurement of body weight) often used to screen for potential toxicants are 
inadequate.  The results obtained here do support the idea that BPA can induce 
alterations to the thyroid hormone system.  While there is a substantial amount of 
evidence that alterations the thyroid hormones during the prenatal period are important 
for neuron, glia, and white matter development (Sharlin et al, 2008; Leonard et al., 
2008; Bernal, 2005. Morreale de Escobar et al., 2004; Berbel et al., 2010), there are no 
studies to date that assess whether T4 alterations at weaning age impact neural 
structure in adulthood.   This study did not collect serum during the time of BPA dosing, 
so it is unknown whether similar changes are seen at this time when the amount and 
magnitude of neural changes are large.   
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Figures and Tables 
Table 1. Maternal Measures 
Dose 
(µg/kg) 
Body 
Weight 
(g) 
Brain  
Weight 
(g) 
Relative Liver  
Weight 
(Liver Weight/BW) 
No. of 
Implantation 
Sites 
Litter 
Size 
Sex Ratio 
(#males/ 
#females) 
0  281.1±7.3 1.93±0.03 0.0594±0.0030 12.2±0.9 10.8±0.9 1.05±0.22 
4  279.7±3.7 1.85±0.04 0.0587±0.0019 12.7±0.4 11.4±0.7 1.06±0.19 
40  281.6±5.2 1.91±0.02 0.0582±0.0009 12.7±0.6 11.8±0.7 0.77±0.10 
400  279.0±4.8 1.91±0.02 0.0617±0.0014 13.0±0.6 12.0±0.6 0.91±0.12 
 
No significant differences were seen in maternal body weight, brain 
weight, relative liver weight, the number of implantation sites, litter size, 
or sex ratio. 
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BPA did not alter body weight in males or females during early postnatal 
development, weaning, or in adulthood. 
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Table 2. Offspring Measures 
 
Dose 
(µg/kg) 
Sex Puberty 
Onset 
(PND) 
Relative Liver 
Weight 
(Liver Weight/BW) 
Brain 
Weight 
(g) 
0 Female 33.2±1.0 0.0330±0.0004 1.85±0.02 
4 Female 32.7±1.0 0.0323±0.0007 1.84±0.01 
40 Female 31.5±0.6 0.0321±0.0005 1.84±0.01 
400 Female 32.5±0.8 0.0323±0.0007 1.84±0.03 
0 Male 43.2±0.6 0.0332±0.0007 1.99±0.03 
4 Male 42.6±0.4 0.0327±0.0007 1.97±0.02 
40 Male 42.5±0.3 0.0333±0.0005 1.95±0.02 
400 Male 42.9±0.4 0.0338±0.0006 1.99±0.02 
 
BPA did not alter puberty onset, adult relative liver weights, or brain weights in 
males or females. 
 
Figure 2. Thyroxine Levels 
 
 
 
 
 
 
 
 
A significant treatment effect in females and a nonsignificant trend towards a 
treatment effect in males (p=.09) revealed a nonmonotonic dose response curve 
with the moderate dose showing a significant decrease in T4 levels at 
weaning.*p<.05 
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Chapter 3: 
Effects of Perinatal Bisphenol A on Radial Arm Maze Behavior 
 
Introduction 
Particular concern has arisen regarding the potential for perinatal exposure to 
BPA to exert long-lasting changes in behavior.  The National Toxicology Program (NTP) 
(2008) reviewed published studies to conclude that there are some concerns for 
adverse effects of developmental exposure of BPA to fetuses, infants, and children on 
the brain and behavior.  However, the available investigations that examine long-lasting 
changes in behavior in both males and females are limited.  The majority of animal 
studies investigating behavioral changes in response to perinatal exposure to BPA have 
focused on anxiety-related behaviors and novelty seeking.  Low dose perinatal BPA 
increases anxiety as evident by a reduction in entries or time spent in open arms in the 
elevated plus maze (Patisaul & Bateman, 2008; Cox et al., 2010; Ryan & Vandenbergh, 
2006) or by a decreased time spent in a novel area in a novel preference test (Adriani et 
al., 2003).  Several additional studies using the elevated plus maze or open field task 
reported a loss of sex differences (Gioiosa et al., 2007; Rubin et al., 2006; Fujimoto et 
al., 2006; Kubo et al., 2001; 2003).  In Gioiosa et al. (2007), control females spent more 
time in the center area of an open field than control males.  However, male mice 
exposed to 10µg/kg/day BPA significantly increased their time in the center in 
comparison to male controls and females exposed to the same dose of BPA slightly 
decreased their time in the center.  Similar results, i.e. abolishment of sex differences, 
were found when these mice were tested in an elevated plus maze and a novelty task.  
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Lastly, increases in basal levels of corticosterone in females and increases in levels 
after exposure to a novel environment (Poimenova et al., 2010) support the idea that 
perinatal BPA results in long-lasting changes in anxiety and anxiety-related behavior 
that may be mediated by changes in stress hormones. 
 Long-term effects of perinatal BPA on social behavior are not as extensive or 
definitive as those demonstrated in tasks that assess anxiety.  40µg/kg/day and 
400µg/kg/day BPA given during early development affected different aspects of play 
behavior in a dose dependent manner with some behaviors, such as play between 
females being increased and other aspects of social behavior, such as sociosexual 
interest, being decreased (Dessi-Fulgheri et al., 2002).  However, in a related study in 
which female rats were exposed to 40µg/kg/day, play behavior directed towards males 
decreased, while there was no change in play directed towards other females (Porrini et 
al., 2005).  These findings were observed at ages that correspond to adolescence.  
Consequently, it is unknown whether changes in social behavior persist into adulthood.  
 Lastly, and most relevant to the studies proposed here, are changes to learning 
and memory after exposure to low doses of BPA during the perinatal period.  Several 
studies have employed the water maze to determine whether perinatal exposure to BPA 
alters spatial learning and memory (Carr et al., 2003; Xu et al., 2010; Goncalves et al., 
2010; Nakamura et al., 2012).  In this task, rats are trained over the course of several 
days to find a hidden platform using spatial cues located in the training room.  On a 
probe trial, the platform is removed and different measures are utilized to determine 
memory retention.  Although a number of studies mentioned above have used the water 
maze, differences in methodology and observed effects make it difficult to extrapolate 
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whether BPA has long-lasting effects on behavior in this task.  Carr et al., (2003) 
administered either 100µg/kg/day or 250µg/kg/day of BPA to males and females from 
postnatal days 1-14 and rats were trained and then tested at ages corresponding to 
adolescence (from PND 33-40).  During the acquisition phase of this task, control males 
and females exhibited a sex difference in the slope of performance in terms of latency, 
while rats exposed to 100ug/kg/day did not.  However, no significant differences 
between treatments were seen during acquisition.  Females treated with the larger dose 
of BPA also showed an increased amount of time spent in the target quadrant on a 
probe trial, while neither dose of BPA had an effect on male behavior.   
While this study (Carr et al., 2003) stated conclusions that BPA alters 
performance in the water maze, there are important methodological considerations that 
make interpretation of these results difficult.  For instance, the age at testing 
corresponds to an approximate time when females are exhibiting or already have 
exhibited physical onset of puberty.  In contrast, males were unlikely to have exhibited 
external markers of puberty at this age.  Therefore, these differences in the status of 
puberty may be contributing to the differences in effects observed between the two 
sexes.  This study only reported latency measures during acquisition and it was not 
tested whether BPA impacted locomotor activity, such as swim velocity.  For these 
reasons, path length is a better measure of learning in this task.  Also, significant 
differences between treatments in the probe trial without differences in acquisition make 
interpretation difficult, as these results could be indicative of perseverative behavior.  
Lastly, it is not known from this particular study whether these alterations would persist 
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into adulthood.  Therefore, the following discussion of other studies examining the water 
maze will focus on behavior in adulthood.  
Several other studies have utilized the water maze to examine the potential of 
early exposure to BPA to disrupt cognitive behavior in adulthood.  Goncalves et al., 
(2010) did report some differences in performance in the water maze in male and 
female rats.  Exposure to 40µg/kg/day resulted in enhancements or impairments 
between different treatment groups in terms of latency and path length during the 
training days in this study (Goncalves et al., 2010) depending on whether exposure 
occurred during gestation, during lactation, or during both developmental time points.  
However, due to the fact that rats showed differences in swim velocity which are 
indicatively of potential disruptions to motor ability, only path length (and not latency to 
find a platform) are valid measurements.  Impairments were evident during training days 
2 and 4 between rats exposed to BPA during lactation only (in terms of path length) and 
during the probe trial in rats exposed during gestation.  Another study examining 
performance in the water maze did find impairments in the higher dose groups 
(50mg/kg, 5mg/kg, .5mg/kg), but not the lowest dose group (.05mg/kg) during learning 
and impairments for memory of the task on the probe trial in the 50mg/kg and .5 mg/kg 
treatments group compared to controls (Xu et al., 2010).  In contrast, another study 
failed to find significant effects on water maze performance after subcutaneous 
injections of 20µg/kg/day during gestation and lactation to the dams (Nakamura et al., 
2011).   
Only a few tasks other than the water maze have been employed to determine 
potential effects of BPA on learning and memory.  Two of the previously mentioned 
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studies reported impairments in the passive avoidance task in adult males and females 
(Goncalves et al., 2010; Xu et al., 2010).  Kubo et al. (2001) found that 1.5mg/kg/day 
abolished a sex difference in a passive avoidance task, although this dose is unlikely to 
mimic human exposures.   
Although these studies may suggest that bisphenol A may alter water maze and 
passive avoidance performance, there are important considerations with respect to task 
differences.  The water maze utilizes the fact that rats find the water aversive, and it has 
been shown that exposure to water at a temperature range used in the previously 
discussed studies (around 25ºC) results in an increase in serum corticosterone levels 
(often used as an indicator of stress) of two fold compared to rats not exposed to the 
water (Sandi et al., 1997).  Given the available and consistent demonstrations of 
changes in anxiety behavior after BPA (Patisaul & Bateman, 2008; Cox et al., 2010; 
Ryan & Vandenbergh, 2006; Adriani et al., 2003; Gioiosa et al., 2007; Rubin et al., 
2006; Fujimoto et al., 2006; Kubo et al., 2001; 2003), water-induced changes in anxiety 
and stress may confound results found with the water maze behavior.  Additionally, 
similar concerns arise when reviewing studies in which passive avoidance behavior is 
altered after early exposure to BPA (Goncalves et al., 2010; Kubo et al., 001; Xu et al., 
2010).  This task also uses an aversive stimulus (footshock) to induce motivation to 
perform the task.  Therefore, it is important to assess behavior in appetitive tasks to 
avoid these potential confounds.    
Only one study has utilized dry maze tasks to assess effects of BPA on learning 
and memory.  In Ryan and Vanderberg (2006), female mice were exposed to 0, 2, or 
200µg/kg/day BPA during gestation and lactation.  Mice were then tested on the Barnes 
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maze around PND 42 and the radial arm maze about 1 week later.  No treatment effects 
of BPA were seen in either task.  Also, a lack of learning in the controls in the radial arm 
maze in this study suggests that motivation/reward to solve the maze was not sufficient 
or that not enough trials were given to show learning over time, making it difficult to 
draw conclusions from this study.   
 Given the available evidence, it is possible that BPA alters behavior or sex 
differences in behavior.  However, it is obvious that more studies are needed to identify 
dose-dependent effects of perinatal exposure to BPA, especially with respect to 
cognitive-related behaviors.  Many of the studies discussed in the previous paragraphs 
failed to utilize a wide range of doses of BPA relevant to human exposure and/or only 
used either males or females.  Furthermore, several of the behavioral studies did not 
tightly control for BPA exposure from other sources, such as water, food, or cages.  
Controlling for outside BPA exposures and using several doses of BPA, the current 
study examined the effects of early developmental exposure to BPA on acquisition of a 
17-arm radial maze task.  Several reasons exist for why this behavioral task was 
implemented.  First, a 17-arm radial maze task was utilized since it is a task that is 
considered challenging, making it more likely to discern smaller effects of chemical 
exposures.  Second, previous results from our lab and others have demonstrated sex 
differences in performance on this radial arm maze task, with males committing fewer 
reference and working memory errors than females (Seymoure et al., 1996; La Buda et 
al., 2002; Beatty, 1984; Mishima et al., 1986; Tees et al., 1981; Williams & Meck 1990).  
The current experiment utilized several doses of BPA to determine effects of perinatal 
exposure on radial arm maze behavior in adult males and females. 
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Methods 
Radial Arm Maze 
Starting in adulthood (PND 85), two female and two male rats from each litter of 
those described in Chapter 2 were weighed and placed on food restriction.  During this 
time, rats were daily given 3 pellets of the food reward that was used during behavioral 
training.  The target weight was 85-90% ad libitum and due to sex-specific increases in 
body weight during this age, the target weight was increased by 5 grams weekly for 
males only.  Only 1 female and 1 male from each litter were tested in the radial arm 
maze.  Habituation began 5 days after the start of food deprivation and consisted of 
placing rats in the center platform of a 17-arm radial maze.  One pellet of food reward 
was placed in each arm in a random location and 2 pellets where placed in the center 
platform.  Rats were allowed to run freely for 12 minutes for 4 consecutive days to 
acclimate rats to training procedures. 
Starting on the day after completion of habituation, rats were trained for 6 
days/week for 4 weeks.  Prior to training, one food reward pellet was placed at the end 
of 11 out of the 17 arms.  The remaining arms did not contain a food reward.   The arms 
that were baited and unbaited were consistent in their spatial location throughout the 
entire training period, so that rats had to remember not only which arms they had 
already visited within a day, but also the arms that never contained food reward.  Once 
a day, rats were placed in the center of the maze and allowed to explore freely until all 
food rewards were eaten or for a maximum of 15 minutes.  An entry into an arm was 
recorded when all four limbs were inside an arm.  Reentry into a previously baited arm 
was termed a working memory error, while entry into an arm that never contained food 
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rewards was termed a reference memory error.  After training, rats were placed back 
into their home cage with their untrained littermate, and the maze was cleaned with a 
10% ethanol solution prior to training of the next rat.  The arms were rotated 2 positions 
every 4 days to reduce the possibility that remaining odor cues could be used to learn 
this task. 
Statistical Analysis 
 Analyses of reference and working memory errors were performed using 
repeated measures ANOVAS that included all of the treatments.  Cohort was used as a 
covariate in all of the comparisons due to significant differences between the two 
cohorts (p<.05) in most measures.  Due to the expectation that males and females may 
exhibit different responses to BPA, female and male scores were analyzed separately 
when assessing potential effects of treatment.  In cases where indications for treatment 
by block interactions occurred, posthoc ANOVAs using treatment as an independent 
factor and cohort as a covariate compared scores of different treatment groups at 
individual blocks.  Repeated measures ANOVAs with sex as the independent factor and 
cohort as a covariate were also performed between male and female controls to 
determine whether sex differences were apparent.  Statistical significance was set at 
p<0.05. 
 Additional analyses were performed with all treatment groups to compare radial 
arm maze performance in both sexes.  Analyses of working and reference memory 
errors were analyzed using repeated measures ANOVAS, with the between-subject 
variable being treatment.  Litter was used as the unit of variance and sex was nested 
within litter.  Cohort was used as a covariate in these analyses. 
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Results 
Reference Memory Errors 
 All behavioral graphs depict averages for each block (6 days) of training.  
Reference memory errors are displayed in Fig 3.  There was no significant treatment 
effect or interaction of treatment x block in females.  However, there was a significant 
effect of block (p<.05) in females.  An analysis of male reference errors revealed a weak 
trend towards a treatment x block interaction (p=.08) and a significant effect of block 
(p<.01).  Comparisons at each block between the different treatment groups showed 
several minor indications for alterations in errors in males.  In block 2, there were trends 
towards decreased errors in the 40µg/kg compared to the control group (p=.09) or the 
4µg/kg group (p=.07).  In block 4, the males that received 40µg/kg BPA had significant 
increases in errors compared to controls (p<.05), while the 4µg/kg (p=.07) and 400µg/kg 
(p=.08) also exhibited trends towards increased errors compared to controls.  No 
significant sex differences were seen between the female and male control groups.  
When comparing all treatment groups and both sexes, there were no significant effects 
of treatment or sex.  Samples sizes for each treatment and for each sex were as 
follows: 0µg/kg = 9, 4µg/kg = 10, 40µg/kg = 13, 400µg/kg = 12. 
Working Memory Errors 
 Working memory errors are shown in Fig 4.  No significant treatment, treatment x 
block, or block effects were observed in males or females.  No significant sex 
differences were seen between the female and male control groups.  However, when 
comparing all treatment groups with both sexes included in the analysis, there was a 
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significant effect of sex (p<.05).  Samples sizes are the same for working memory errors 
as were reported for reference memory errors. 
Discussion  
 The current study is the first to measure whether perinatal exposure, at a time 
that is meant to mimic human exposure, affects both reference and working memory in 
adult rodents, as assessed through training on the 17-arm radial maze.  The results 
indicated only a modest effect of BPA treatment in males in reference memory errors 
with indications for differences occurring mostly during the last week of training.  
However, the only significant difference was for slight increases in reference memory 
errors in block 4 in the 40ug/kg group (with an average of approximately 2 more errors) 
compared to controls.  Although the results of this study suggest that slight impairments 
in learning in males may result from BPA exposure, it is apparent that large changes in 
radial arm maze behavior are not induced.   
Only one previous study examined the potential for BPA to impact radial arm 
maze behavior, and this study examined female mice and examined performance in an 
8-arm version of the task (Ryan and Vandenbergh, 2006).  This study exposed the 
dams to 2 or 200µg/kg/day through oral administration by gavage to the dams from 
gestation until the offspring were weaned.  Additionally, mice were ovariectomized 
around PND 28, and testing on the RAM behavior occurred around PND 45.  Even with 
the methodological differences between Ryan and Vandenbergh (2006) and the current 
study, such as age of testing, species, dose, and surgical procedures, a similar lack of 
large effects were found.  The current study suggests that although some changes in 
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learning behavior may occur in males, these differences are small in magnitude and are 
unlikely to contribute to drastic changes to cognitive learning. 
This cognitive task was originally chosen due the fact that a large number of 
arms (compared to the 8-arm radial maze) would make this task difficult and more likely 
to see small differences.  If a task is too easy and is learned quickly, it would make it 
difficult to see small impairments in learning.  On the other hand, if a task is too 
challenging, detecting small learning enhancements would be difficult.   However, there 
was a significant effect of block in both males and females in reference memory errors 
with performance improving across the weeks of training.  Therefore, it would be 
possible to see both enhancements and impairments in this measure.  Contrary to 
reference memory errors, no significant effects of block were seen in either sex in 
working errors.  Although the graph does seem to show that performance in this 
measure improves over time, the large variability in errors may contribute to inability to 
detect significant improvement over time.    
No positive controls were used in this study because the mechanism in which 
BPA could alter performance on this task is unknown.  Radial arm maze performance in 
the 8-arm version of this task has been shown to be responsive to manipulations to a 
wide variety of hormones, such as estrogen, testosterone, and corticosterone (Davis et 
al., 2005; Sprizter et al., 2011; Roskoden et al., 2005).  Also, environmental factors, 
such as environmental enrichment, can alter performance 17-arm radial maze 
(Seymoure et al., 1996), indicating that this task is both appropriate and useful in 
determining effects of potential endocrine disruptors on cognitive behavior. 
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Contrary to previous reports from our laboratory in this task (Seymoure et al., 
1996) and in other radial arm maze tasks (La Buda et al., 2002; Beatty, 1984; Mishima 
et al., 1986; Tees et al., 1981; Williams & Meck 1990), no sex differences were seen 
between male and female controls in either reference or working memory errors.  
However, when comparing all treatment groups with both sexes included in the 
analysis, there was a significant effect of sex in working errors.  This suggests that it 
may have been possible to detect sex differences in controls in this measure if more 
rats had been added to the control group.   
There may be several reasons for why no sex differences were observed when 
comparing the male and female control groups as has been reported in a previous study 
using the 17-arm radial maze (Seymoure et al., 1996).  This discrepancy may be due to 
handling of both the dam during gestation and pups during early postnatal development 
that occurred in this study and not in Seymoure et al. (1996).  Although no studies have 
directly tested for sex-dependent responses to early handling on radial arm maze 
behavior, there is evidence that handling during the early postnatal development can 
affect stress-related measures in males and females differently.  For example, females 
failed to adapt to chronic stress as assessed by immobility time in a forced swim task, 
while males exhibited no changes in this measure after chronic stress (Papaioannou et 
al., 2002).  Males also show exaggerated adrenocorticotropin hormone (ACTH) levels in 
response to shock after being handling during the first 10 days of postnatal 
development, while the response in female ACTH levels are unaffected by early 
handling (Erskine et al., 1975).  Additionally, the responses to early postnatal handling 
on corpus callosum area (Berrebi et al., 1988) and turnover of serotonin in prefrontal 
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cortex (Duchesne et al., 2009) are also dependent on sex.  Another potential factor that 
could disrupt sex differences in this study is the administration of oil during early 
postnatal development.  Pups are not normally exposed to oil during this developmental 
period and it is currently unknown as to what changes this early manipulation might 
induce in adult behavior. 
In conclusion, early exposure to BPA only leads to slight impairments in 
reference memory in males mostly late in training in the 17-arm radial maze task. 
Behavior in the radial arm maze in females is not altered by exposure to BPA.  
However, changes in structure of the brain after early exposure to BPA are still 
important to measure given the past demonstrated alterations to anxiety and stress-
related behaviors. 
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Figure 3. Reference Memory Errors 
 
 
 
 
 
 
 
BPA did not alter reference memory errors in females. There was a trend 
towards a treatment x block interaction in males (p=.08). The only significant 
difference was between 0 and 40 in block 4.*p<.05 
 
Figure 4. Working Memory Errors 
 
 
 
 
 
 
 
BPA did not alter working memory errors in males or females. 
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Chapter 4: 
Effects of Perinatal Bisphenol A on Anatomy of the Prefrontal Cortex 
 
Introduction 
 To date, evidence suggests that BPA exposure during early development has the 
ability to alter structure of the brain.  One must consider the magnitude and variety of 
changes, including proliferation, migration, and differentiation that the brain must 
undergo to reach the level of maturation that is observed after gestation and early 
development.  The dynamic state of this system coupled with the large number of 
processes that must occur in a time and region-specific manner make this age 
particularly susceptible to perturbations by potential toxicants.  In addition to BPA 
having actions at both estrogen and thyroid receptors (two hormones that are involved 
in the development of neural systems), it also possesses the ability to cross the blood-
brain barrier (Sun et al., 2002).  Consequently, it is imperative to determine whether 
endocrine disruptors, such as BPA, alter neuroanatomical development of the brain. 
One way in which developmental exposure to BPA could induce changes in 
neuroanatomy is by altering neuron number.  Several studies investigating neuron 
number in different areas of the brain in both males and females have demonstrated 
alterations in adult sex differences after exposure to BPA.  For instance, sex differences 
in neuron number and volume of the locus coeruleus were completely reversed when 
rats were exposed to 30µg/kg/day, 300µg/kg/day, or 1.5mg/kg/day BPA during early 
development (Kubo et al., 2001; 2003).  Additionally, BPA administration abolished sex 
differences in corticotropin-releasing hormone (CRH)-immunoreactive neurons in the 
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bed nucleus of the stria terminalis (Funabashi et al., 2004).  This effect was due to a 
BPA-mediated increase in neurons in males and a decrease in females.  In the same 
study (Funabashi et al., 2004), CRH neuron number in the sexually dimorphic nucleus 
of the preoptic area of the hypothalamus was not changed in males or females, 
suggesting that changes in sex differences due to BPA are brain-area specific.  Two 
studies have demonstrated that BPA changes neuron number in the anterior 
periventicular nucleus of the hypothalamus (AVPV), an area important for regulation of 
reproductive functions.  BPA decreased tyrosine hydroxylase-positive neuron number in 
females, while having no effect in males, resulting in abolishment of sex differences 
exhibited in controls (Rubin et al., 2006).  In this study, only the anterior subregion of 
this nucleus was affected by BPA treatment, again lending support to the idea that BPA 
effects are likely confined to particular regions of the brain.  Additionally, the number of 
oxytocin-immunoreactive neurons in the AVPV was increased in adult female rats after 
early developmental exposure to 50µg/kg/day and 50mg/kg/day of BPA (Adewale et al., 
2011).  Males were not examined in this study, so it is unknown whether there are sex 
differences in this response.  Interestingly, all of the above mentioned studies that found 
changes in sex differences in the brain after BPA exposure were limited to regions 
where females have more neurons than males.  These studies mentioned above 
indicate that some sex differences in neurons are altered by BPA.  However, more 
studies that investigate changes in neurons in both males and females and in different 
areas of the brain, such as those involved in mediating cognitive function, are 
necessary.   
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Although it is very likely that BPA may contribute to changes in neuron number in 
a variety of different brain areas, virtually no evidence is available to determine whether 
similar effects are seen in areas associated with learning and memory behavior, such 
as the hippocampus and prefrontal cortex.  An approximate dose of 70µg/kg/day BPA 
given during gestation and lactation decreased the density of NeuN-positive neurons in 
the hippocampus at PND 20 in males and females (Kunz et al., 2011).  However, 
conclusions that can be drawn from this study are very limited due problems associated 
with studies that only report density measures.  Assessment of neuronal (and glial) 
density in the brain does not accurately represent changes in total number.  For 
example, a decreased density could potentially be accompanied by increases in total 
volume, equating to no changes in the total number of cells.  For this reason, 
stereological analysis of neuron number, in which density is multiplied by volume, is 
preferred. 
Studies that have attempted to determine whether glial cells are affected by BPA 
have mainly concentrated on changes to GFAP expression in astrocytes.  Early 
developmental exposure to BPA increased density of GFAP staining in the cingulum at 
PND 20 (Kunz et al., 2011) and an increase in astrocyte process density in the 
hippocampus was demonstrated in male rodents exposed during adulthood (Leranth et 
al., 2008).  An increase in GFAP expression has also been demonstrated in vitro after 
application of BPA (Yamaguchi et al., 2006; Miyatake et al., 2006).  One study has 
investigated the effects of BPA on precursor cells of oligodendrocytes, which are 
responsible for myelination of axons in the central nervous system.  In vitro treatment of 
BPA blocked differentiation of oligodendrocyte precursor cells induced by application of 
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thyroid hormone (Seiwa et al., 2004).  Currently, it is unknown whether developmental 
exposure of BPA in vivo has long-lasting impacts on the number of astrocytes or 
numbers of other types of glia, such as microglia or oligodendrocytes. 
In addition to neuroanatomical changes associated with neurons and glia, there 
is evidence to support the idea that BPA exposure contributes to alterations in synapses 
and spines.  BPA was found to dose-dependently alter synaptic density in the 
hypothalamus in an in vitro model, with an increase demonstrated at a lower dose and 
decrease demonstrated in a higher dose (Yokosuka et al., 2008).  Across several 
studies, it has also been shown that BPA exposure in adulthood prevents the 
synaptogenic response to both estrogen and testosterone (Leranth et al., 2008a; 2008b, 
MacLusky et al., 2005).  To elaborate, 50µg/kg/day of BPA administered during 
adulthood to female nonhuman primates attenuated an estrogen-mediated increase in 
the number of spine synapses in both the hippocampus and prefrontal cortex (Leranth 
et al., 2008a).  Additionally, the testosterone-induced increases in spine synapses in the 
prefrontal cortex and hippocampus was not seen if male rats were exposed to 
300µg/kg/day of BPA (Leranth et al., 2008b), and female adult rats given the same dose 
of BPA were found to have an attenuation of estrogen-mediated increases in 
hippocampal spine density (MacLusky et al., 2005).  These findings point to a 
susceptibility of adult spines to be impacted by BPA, although the ability for exposure 
during early development to exert similar effects in a long-lasting manner remains 
unknown.   
BPA may perturb different developmental processes, such as proliferation, 
differentiation, and apoptosis, which may contribute to the previously mentioned 
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changes in adult neuroanatomy.  Several studies support the idea that BPA alters both 
proliferation and differentiation of neural progenitor cells (NPCs), which can develop into 
neurons, astrocytes, or oligodendrocytes (Okada et al., 2008; Okada et al., 2010; Kim et 
al., 2007).  In NPCs isolated from the cerebellum, BPA dose-dependently suppressed 
proliferation and increased cytotoxicity, and these effects were potentially mediated by 
activation of certain protein kinases and increases in reactive oxygen species (Kim et 
al., 2007).  Further support for the idea that BPA induces apoptosis comes from 
evidence in which BPA increased reactive oxygen species, calcium, and 
phosphorylation of mitogen-activated protein kinases, along with activation of caspases, 
in the hippocampus (Lee et al., 2008).  Another potential mechanism for changes in 
neurons or glia could be due to a BPA-induced rise in glutamate and NMDA receptors in 
the hippocampus (Kunz et al., 2011; Lee et al., 2008) given that BPA can exacerbate 
glutamate-induced neuronal death in organotypic slices obtained from PND 8 rats in the 
CA3 region of the hippocampus (Sato et al,. 2002).   
Migration is another developmental process that may be susceptible to 
perturbations induced by BPA.  Subcutaneous injections of 20µg/kg/day of BPA to 
pregnant mice during early gestation decreased BrdU (which labels dividing cells) in the 
ventricular zone and increased labeling in the cortical plate when brains from embryos 
were analyzed at day 16.5, 2 days after the BrdU injection (Nakamura et al., 2006).  
During this period of development, most neurons radially migrate from the ventricular 
zone to the cortical plate (which develops into the cerebral cortex).  In addition, this 
same study failed to find any changes in proliferation of precursor cells, leading to the 
conclusion that BPA exposure resulted in accelerated neuronal migration (Nakamura et 
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al., 2006).  In a later study by the same research group, evidence for accelerated 
migration of somatosensory cortex neurons after BPA exposure was evident at 3 weeks 
after birth, but these differences disappeared by 12 weeks after birth (Nakamura et al., 
2007).  BPA exposure also resulted in abnormal thalamocortical and corticothalamic 
projections in the third postnatal week that persisted until the 12th postnatal week 
(Nakamura et al., 2007).  This study suggests that while compensation prior to 
adulthood can occur with respect to migration of neurons in the cortex, BPA-induced 
changes in projections of axons are long-lasting.  Together, the available evidence 
discussed in the preceding paragraphs supports the potential of BPA to alter the 
trajectory of developmental processes that are necessary for normal numbers of 
neurons and glia in adulthood.  
As discussed above, some studies have examined whether developmental BPA 
alters neuron number in adulthood in several brain areas and other studies have 
attempted to discern whether developmental processes that contribute to this endpoint 
are disturbed.  To date, no studies have investigated whether developmental exposure 
to BPA alters adult neuron and glia number in the medial prefrontal cortex, a brain area 
important for cognitive functioning.  By the 10th day after birth (which corresponds to the 
end of dosing in the current study), neurons in the rat prefrontal cortex have undergone 
a myriad of developmental processes such as proliferation, migration, differentiation, 
and apoptosis so that most of the layers of the prefrontal cortex are anatomically 
distinguishable (van Eden & Uylings, 1985).  Although anatomical development is by no 
means complete, particularly with respect to differentiation, apoptosis, and dendritic 
alterations (van Eden & Uylings, 1985; Nunez et al., 2001; Koss et al., 2010), the rate 
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and variety of processes in early development suggest that this is a critical period that 
could be particularly sensitive to toxicological substances or other insults.   
Previous evidence from our lab suggests that there are sex differences in the 
development of the cortex.  For instance, the trajectory of apoptosis in the developing 
posterior cortex (which later develops into the primary visual cortex) is different between 
males and females, in that males exhibit a larger peak at PND 7 and females exhibit a 
larger peak at PND 11 and 25 (Nuñez et al., 2001).  While no studies have measured 
apoptosis during early development in the prefrontal cortex, this previous work points to 
a possibility that sex differences in timing of apoptosis in early development could occur, 
potentially affecting adult neuron and glia number. 
Other work from our laboratory has shown that anatomy of the medial prefrontal 
cortex (mPFC) develops in a sex-specific manner past early development.  For 
example, between PND 20 and 35, both sexes showed dendritic growth, while dendritic 
pruning between PND 35 and 90 was only apparent in females (Koss et al., 2010).  
Furthermore, while neuron number in the mPFC is similar between male and female 
rats at PND 35, there are sex differences in neuron and glia number in adulthood 
(Markham et al., 2007).  Emergence of sex differences in adulthood is characterized by 
neuron loss that occurs between PND 35 and 90, which is present in both sexes, but 
more exaggerated in females.  Consequently, females have fewer neurons and glia in 
the mPFC than males in adulthood (Markham et al., 2007).  It is likely that endogenous 
hormones, such as estrogen, progesterone, and testosterone are contributing to these 
adult sex differences, and work in our lab is currently underway to directly test this 
hypothesis by removing gonads prior to puberty and assessing whether adult sex 
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differences in prefrontal cortex anatomy are altered.  Although the preceding discussion 
is focused on changes that occur after administration of BPA in the current study, 
endogenous hormones during early development may provide a foundation for these 
later changes.  Hence, exposure to BPA during early development may produce 
alterations in the timing, intensity, or direction of sex-dependent developmental changes 
that occur between adolescence and adulthood.  Accordingly, these differences may 
contribute to a sex-dependent response to endocrine disruptors, such as BPA.  The 
current study aims to clarify whether BPA alters adult neuron and glia number in the 
mPFC in a sex-dependent manner. 
Methods 
Histology 
After the last day of training in the previously described radial arm maze task in 
Chapter 3, food was returned ad libitum immediately.  2-5 weeks after the completion of 
training in the behavior task, rats were sacrificed.  On the day of sacrifice, rats were 
injected with 100mg/kg sodium pentobarbital and perfused with 0.1 M phosphate 
buffered saline (PBS) for 4 minutes followed by 4% parafomaldehyde in PBS for 5 
minutes.  Brains were removed and weighed.  All brains were stored in the 4% 
paraformaldehyde solution for nine days, transferred to a 30% sucrose solution for 3 
days, and then sectioned on a freezing microtome.  Every fourth 60µm section was 
mounted on slides and then stained with Methylene Blue/Azure II on the following day. 
Cortical and White Matter Volume 
 On a Zeiss microscope equipped with camera lucida, the ventral mPFC 
(infralimbic and prelimbic regions) was parcellated based on differences in 
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cytoarchitecture as described previously (Markham et al., 2007; Van Eden & Uylings, 
1985). The boundaries of PL/IL within a section were determined through 
cytoarchitectural characteristics of these areas and the cortical regions bordering them.  
Within and between cohorts, boundaries were randomly redrawn to confirm consistency 
within 5% of the original parcellations.  Prefrontal gray matter volumes were parcellated 
from the most anterior section where the underlying white matter appears and continued 
on every mounted section until the appearance of the genu of the corpus callosum, 
resulting in analysis of 4-6 sections for each brain. Within each parcellation, boundaries 
were drawn for the layers 2/3 and layers 5/6 separately. Additionally, white matter 
adjacent to the mPFC was parcellated.  All drawings were scanned into a computer, 
areas were measured with Image J, and post-shrinkage thickness for each layer was 
measured to obtain an average thickness.  The volumes were calculated with the 
Cavalieri method as the product of the areas and the tissue thickness between the 
saved sections with separate calculations for the upper and lower layers of the gray 
matter. 
Neuron and Glia Number 
Total numbers of neurons and glia were determined as described previously 
(Markham et al., 2007; Koss et al., submitted) using the optical disector with the 
Stereoinvestigator program (Microbrightfield).  Neuron and glia density were quantified 
separately for the layers 2/3 and layers 5/6 of the mPFC.  The computer program 
randomly chose counting frames, which measured 35µm x 35µm (width x height), within 
parcellated boundaries.  Guard zones were set at 1um at the top and bottom of each 
section.  A cell was counted only if the bottom of the cell was within the volume of the 
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counting frame.  Neurons and glia were distinguished based on differences in 
morphological, size, and color characteristics.  At least 400 neurons and 140 glia were 
counted from the layers 2/3 and the layers 5/6 for each animal.  These numbers were 
then divided by the total volume of the counting frames to determine neuron and glia 
density.  The densities for each animal were multiplied by the volume of the structure for 
each animal to determine total number of neurons and glia for individual layers. 
Statistical Analysis 
 Analyses of neuroanatomical measures were performed using ANOVAS that 
included all of the treatments.  Cohort was used as a covariate in all of the comparisons 
due to significant differences between the two cohorts (p<.05) in most measures.  .  Due 
to the expectation that males and females may exhibit different responses to BPA, 
females and males were analyzed separately when assessing potential effects of 
treatment.  In situations where effects of treatment were found when analyzing all dose 
groups, ANOVAS with treatment as an independent factor and cohort as a covariate 
were utilized to compare individual BPA treatment groups to the control group.  
ANOVAs with sex as the independent factor and cohort as a covariate were also 
performed between male and female controls to determine whether sex differences 
were apparent.  Statistical significance was set at p<0.05.  
Results 
Cortical Volume 
 Results for cortical volume are shown in Figure 5.  There were no significant 
changes in volume of layers 2-3 or layers 5-6 in females.  However, in males, there 
were trends towards increases in volume of layers 2-3 and layers 5-6 when all 
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treatments were included in the analyses (p=.06).  In layers 2-3, males exposed to 
400µg/kg/day displayed a significant larger volume when compared to males exposed 
to 40µg/kg/day (p<.05).  Additionally, there was a weak trend for increased volume in 
the 400µg/kg/day compared to the group that received 4 µg/kg/day (p=.09).  In layers 5-
6 in males, there was a significant increase in volume in males that received 
400µg/kg/day compared to the 4µg/kg/day group (p=.05).  Also, there were weak trends 
towards an increase in volume in the 400µg/kg/day group compared to the control group 
(p=.09) and the 40µg/kg/day group (p=.10).  There were no sex differences in volume in 
layers 2-3 or layers 5-6 in controls.  Samples sizes for each treatment and for each sex 
were as follows: 0µg/kg = 8, 4µg/kg = 10, 40µg/kg = 13, 400µg/kg = 11. 
Neuron Number 
Results for neuron number are shown in Figure 6.  There were no significant 
treatment effects in females in neuron number in layers 2-3 or layers 5-6 (Figure A and 
B, respectively). In contrast, there was a significant treatment effect in males in layers 5-
6 when all treatments were included in the analysis (p<.05, Figure 6B).  Posthoc tests 
revealed a significant increase in neuron number in males in layers 5-6 that received 
400µg/kg compared to controls (p=.05) and the 4ug/kg group (p=.07)   Comparison of 
values obtained in control males vs. males that were exposed to 400µg/kg showed that 
the percent increase in neuron number was approximately 15%.  Although analysis did 
not reveal a significant effect of treatment in males in layers 2-3 (Figure 6A), the pattern 
of increased neuron number in the 400µg/kg group was similar to that seen in layers 5-
6.  No significant sex differences were detected when males and females that received 
0ug/kg/day were compared.  Samples sizes for both sexes in layers 2-3 were 0µg/kg = 
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8, 4µg/kg = 9, 40µg/kg = 11, 400µg/kg = 11 and samples sizes for both sexes in layers 
5-6 were 0µg/kg = 8, 4µg/kg =10, 40µg/kg = 13, 400µg/kg = 11. 
Glia Number 
Results for glia number are shown in Figure 7.  There were no significant 
treatment effects in females in glia number in layers 2-3 or layers 5-6. In contrast, there 
was significant treatment effect in males in layers 5-6 when all treatments were included 
in the analysis (Figure 7B, p<.05).  Posthoc tests revealed a significant increase in glia 
number in males in layers 5-6 that received 400µg/kg compared to controls and the 
4µg/kg group (p<.05).  The percent increase of glia number in the 400µg/kg/day group 
compared to the control group was approximately 19%.  Although analysis did not 
reveal a significant effect of treatment in males in layers 2-3 (Figure 7A), the pattern of 
increased glia number in the 400µg/kg group was similar to that seen in layers 5-6.  
Samples sizes for both sexes in layers 2-3 were 0µg/kg = 8, 4µg/kg = 10, 40µg/kg = 13, 
400µg/kg = 11 and samples sizes for both sexes in layers 5-6 were 0µg/kg = 8, 4µg/kg 
=10 , 40µg/kg = 12, 400µg/kg = 11. 
White Matter Volume 
Results for white matter volume are shown in Figure 8.  There were no significant 
treatments effects in females in white matter.  However, there was a weak trend 
towards a treatment effect in the males (p=.09).  Posthoc tests revealed that this trend 
was due to a significantly smaller volume in males that received 4µg/kg compared to 
those that received 400µg/kg BPA (p<.01).  No other differences occurred between 
other treatment groups in males.  Comparison between control males and females 
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revealed a sex difference (p<.05).  Samples sizes for each treatment and for each sex 
were as follows: 0µg/kg = 8, 4µg/kg = 10, 40µg/kg = 13, 400µg/kg = 10.   
Discussion 
 The results found in this study provide the first evidence that early exposure to 
bisphenol A can induce increases in neuron and glia number in the prefrontal cortex of 
males.  This effect is only seen at the highest dose used in the current study, 400µg/kg.  
Importantly, this dose is particularly relevant to exposure that occurs in humans given 
the evidence that 400µg/kg produces serum blood levels in female adult rodents and 
female rhesus monkeys that are similar to those observed in female humans (Taylor et 
al., 2011).  Additionally, effects on neuron number in males in the 400µg/kg dose were 
only significant in layers 5-6, although the direction of changes in layers 2-3 were similar 
to that seen in layers 5-6.  The importance of increased neuron number in males 
become apparent when considering that this neuroanatomical measure is organized 
early in life and is less plastic than other changes.  Unlike other neuroanatomical 
alterations, such as those in dendritic spines or glia number, there are no known 
pharmacological or environmental interventions (i.e. environmental enrichment) that 
could be given either during this period of development or later in life to normalize 
neuron number.  Normal proliferation and apoptosis in neurons occurs during specific 
periods of development in contrast to glia, in which proliferation occurs throughout life.  
Additionally, alterations in neuron number is unlike potential changes in 
neurotransmitter systems, where pharmacological medications could be used to 
attenuate long-lasting effects.  
  
 
57 
 
 The increase in neuron number in males reported here is in contrast with 
predictions made by comparisons with previous studies.  Most of the studies that 
examine changes that may be related adult neuron number in the current study may 
suggest that neuron number would be decreased.  However, there are important 
differences, such as dose of BPA and brain areas examined, between the current study 
and the past studies that could account for differential effects.  For example, a study by 
Kunz et al., (2011) found decreased neuronal density in the hippocampus after 
exposure to BPA.  The estimated dose used in Kunz et al. (2011) was 70µg/kg/day.  
The dose most similar to this in the current study was 40µg/kg/day, where no 
differences in neuron number were observed.  Also, this study only analyzed neuronal 
density and did not account for changes in volume.  In the current study, trends in 
increases in volume suggest that volume changes in the prefrontal cortex may at least 
partially contribute to the changes in neuron number.  This idea of changes in volume 
accounting for changes in neuron number is also supported by a study in which 
alterations to neuron number in the locus coeruleus in response to BPA exposure 
corresponded to changes in volume (Kubo et al., 2001).  Therefore, it is important for 
studies that evaluate BPA-induced alterations in neuronal density or neuron number 
must consider that alterations in volume may also occur.    
The mechanism responsible for the increase in neuron and glia number in males 
in layers 5-6 is unknown.  Alterations to apoptotic, proliferation, or differentiation 
processes could all lead to changes in cell number.  As mentioned in the introduction, 
only one study has attempted to discern whether alterations to proliferation would occur 
after exposure to BPA and they failed to find any significant effects on this measure 
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(Nakamura et al., 2006).  However, this study only examined one dose of BPA 
(20µg/kg/day) which most closely resembles the 40µg/kg/day dose that did not result in 
any changes in neuron or glia number in the prefrontal cortex. Therefore, more studies 
are needed to examine whether expose to 400µg/kg/day alters proliferative process in 
males.   
Cell death is another process that may be contributing to the differences seen in 
the present study.  Several in vitro studies have reported increases in measures of cell 
death in the hippocampus (Lee et al., 2008; Sato et al., 2002), which is contrary to what 
would be predicted in the current study.  However, there is lack of data on what 
concentrations of BPA used in neuronal cultures would equal those used in in vivo 
studies.  One potential reason why males may be susceptible to alterations to cell 
number by exposure to BPA is that males exhibit a peak in apoptosis in the early 
postnatal period (PND 7) in the posterior cortex, while females have peaks in apoptosis 
later in development (Nuñez et al., 2001).  Importantly, this peak in apoptosis in males 
corresponds to the time in which BPA was administered in the current study.  While it is 
not known whether similar time course also exists in the prefrontal cortex, it is possible 
that BPA exposure during the early postnatal period may attenuate an early apoptotic 
peak in males.      
 The full implications of an increase in neuron number in the prefrontal cortex in 
response to early BPA exposure are currently unknown.  However, the direction of 
changes in neuron number found in the current study is similar to what has been seen 
in a preliminary study of autism.  Courchesne et al (2011) found that human male 
children with autism had a significantly larger amount of neurons in the prefrontal cortex 
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(Courchesne et al., 2011).  In this study, the percent increase in neuron number in the 
dorsolateral prefrontal cortex in autistic male children was 79%, which is considerably 
larger than the increase observed in the current study (15%).  Given the large 
discrepancy in these values between the current study and Courchesne et al (2011), it 
is unlikely that BPA exposure alone leads to development of autism.  The biological 
basis of autism likely arises from a variety of neuroanatomical and functional changes in 
the brain.  However, BPA exposure in males during early development may be 
detrimental to populations that already present with other suggested risk factors for 
autism, such as advanced parental age, maternal exposure to known toxicants, and 
maternal viral infections, and genetic predispositions (Grabrucker, 2012; Devlin and 
Scherer, 2012).  It is widely know that human males are much more likely to be 
diagnosed with autism than females (Werling and Geschwind, 2013).  This bias of 
autism in males is consistent with the current study in which only males exhibited an 
increase in neuron number in response to BPA exposure.  More studies are needed to 
determine whether BPA exposure leads to neural changes that are seen in 
developmental disorders, such as autism.   
The increases in glia number in the prefrontal cortex of males exposed to 
400ug/kg/day could be due to changes in astrocytes, oligodendrocytes, and microglia 
due to the fact that the Nissl staining employed in the current study does not distinguish 
between different types of glia.  There is limited evidence that GFAP density is acutely 
increased after exposure to BPA (Yamaguchi et al., 2006; Miyatake et al., 2006; Kunz et 
al., 2011), but long-term effects on GFAP density are unknown.  No studies to date 
have investigated whether BPA directly impacts oligodendrocytes, but one in vitro study 
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did report dose-dependent alterations in neural progenitor cells (NPCs), which can 
develop into astrocytes, oligodendrocytes, and neurons (Okada et al., 2008).  In order to 
confirm that this change was associated with changes in glia, this study did demonstrate 
BPA-induced increases in NG2-positive oligodendrocyte precursor cells.  However,  this 
study reported some decreases in NPCs at higher concentrations of BPA (Okada et al., 
2008), but as stated previously, it is difficult to ascertain what concentrations of BPA in 
culture studies would correspond to doses of BPA used in in vivo studies or exposure 
that occurs in humans.  Therefore, more studies using in vivo administration of BPA are 
needed to determine what types of glia are contributing to the increases seen in this 
current study. 
No significant sex differences were seen in either neuron or glia number in the 
mPFC when male and female controls were compared, even though our lab has 
previously reported sex differences or indications for sex differences when assessing 
these measures in adulthood (Markham et al., 2007; Koss et al., 2012).  Similar to the 
previous chapter where no sex differences were found in radial arm maze behavior, this 
discrepancy may be due to handling of both the dam during gestation and pups during 
early postnatal development that was necessary for the purposes of dosing in the 
current study.  The evidence for different responses between the sexes after early 
postnatal handling is seen in release of ACTH after exposure to shock (Erskine et al., 
1975), area of the corpus callosum (Berrebi et al., 1988), and turnover of serotonin in 
prefrontal cortex (Duchesne et al., 2009).  Also, it unknown how administration of oil 
during postnatal development impacts sex differences in gray matter volume, neuron 
number, and glia number in the mPFC. 
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Lastly, in addition to alterations seen in glia and neuron number in the prefrontal 
cortex of male rats, a significant increase in white matter volume was seen in males in 
the 400µg/kg compared to the 4µg/kg/day treatment group.  No significant differences 
were seen in any treatment group compared to the control group, indicating that the 
difference was due to a non-significant decrease in the 4µg/kg and a non-significant 
increase in the 400µg/kg group.  To date, only one study has assessed potential 
changes in myelination in the cortex or corpus callosum (Kunz et al., 2011).  This study 
failed to find any changes in staining for myelin basic protein with exposure to BPA.  
However, the only dose of 70µg/kg/day used in this study most closely resembled the 
40µg/kg/day group in the current study, which had a similar white volume to the control 
group.  The difference in white matter volume between the two BPA-treated groups 
could be due to alterations in the number of oligodendrocytes given that a significant 
increase in glia number was apparent in males treated with 400µg/kg compared to the 
4µg/kg group. 
In the mPFC, exposure to 400µg/kg/day increases neuron number and glia 
number in males only.  The reason for this particular susceptibility in males is unknown, 
given the evidence that BPA can bind to a variety of receptors, including estrogen, 
androgen, and thyroid receptors (see Welshons et al., 2006).  Future studies are 
needed to assess the mechanism for these changes and the specific type of cells (as in 
the case of glia) that are contributing to these changes.    
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Figures 
Figure 5. Volume of the Prefrontal Cortex 
 
 
 
 
 
 
 
BPA did not alter cortical volume in females. There were trends towards 
treatment effects in males in both layers 2-3 and layers 5-6 (p=.06). *p<.05  
 
 
Figure 6. Neuron Number in the Prefrontal Cortex 
 
 
 
 
 
 
 
 
BPA did not alter neuron number in females. There was a significant increase in 
neurons in males when comparing the control vs. the 400µg/kg. *p<.05 
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Figure 7. Glia Number in the Prefrontal Cortex 
 
 
 
 
 
 
 
 
 
BPA did not alter glia number in females. There was a significant increase in 
neurons in males when comparing the control to the 400µg/kg or the 4µg/kg 
group. *p<.05 
 
 
Figure 8. White Matter Volume 
 
  
 
 
 
 
 
 
BPA did not alter white matter volume in females. There was a significant 
increase in white matter volume in males when comparing the 4µg/kg males to 
the 400µg/kg males. *p<.05 
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Chapter 5: 
General Conclusions 
  
 The current studies demonstrated that BPA has no effects on measures 
commonly used in toxicology to assess general growth and development and minimal 
effects on cognitive behavior, as assessed in the radial arm maze.  However, significant 
increases in both neuron and glia number in the medial prefrontal cortex in males only 
in layers 5-6 suggest that this chemical has long-lasting effects on the anatomy of the 
prefrontal cortex.  While the current safe reference dose for humans used by the U.S. 
EPA and FDA is 50µg/kg/day, measures of blood serum levels in rodents and non-
human primates indicate that exposure to larger doses of BPA (400µg/kg/day) 
correspond to blood levels seen in humans (Taylor et al., 2008).  This suggests that the 
dose of 400ug/kg/day reflects exposure that may occur in humans. 
 The use of different doses in the current study was integral in evaluating the 
potential of BPA to disrupt T4 levels, behavior, and anatomical changes in the prefrontal 
cortex.  Many previous studies that have examined similar endpoints in adulthood only 
utilize one or two doses of BPA, potentially missing the ability to detect specific changes 
that occur only at certain doses.  In particular, the results of T4 levels at weaning 
showed that BPA has the potential to impact physiology in a nonlinear manner, an idea 
that has been highlighted in recent reviews describing the effects of endocrine 
disruptors on numerous endpoints (Vandenberg et al., 2009; Vandenberg et al., 2012; 
Vom Saal and Hughes, 2005).  While this theory is not new to the field of endocrinology, 
it has not been fully integrated into the field of toxicology.  The current practices by 
  
 
65 
 
agencies that are responsible for determining safe reference doses for toxicological 
chemicals review evidence to determine the lowest observed effect level and assume 
that doses below these levels are safe.  Therefore, it is important for federal agencies to 
adopt new practices when determining safe reference doses for human exposure to 
chemicals. 
 In comparing the results from the different chapters, males seemed particularly 
susceptible to perturbations induced by BPA on behavior and on the anatomy of 
prefrontal cortex in the current study.  The mechanism that contributes to the male 
susceptibility is unknown, as there is evidence that BPA binds to receptors of many 
hormones, such as thyroid, estrogen, and androgen receptors (Welshons et al., 2006; 
Wolstenholme et al., 2011).  In contrast to the male susceptibility seen with the anatomy 
and behavior, significant differences were seen in females with regards to changes in 
T4, while males showed similar patterns of changes in T4.  Therefore, although no 
differences in behavior or anatomy were seen in females, it is possible that BPA could 
also impact functioning of other neural measures in females.  However, more work 
needs to be done in order to determine that BPA directly impacts T4 serum levels 
during the time at which dosing occurs.    
 Although some indications for alterations in radial arm maze behavior were seen 
in males, it is unlikely that the increases in neurons and glia were directly responsible 
for these behavioral changes.  Significant behavioral changes were seen in the 
40ug/kg/day group, but neuron and glia number alterations were seen in the 
400ug/kg/day group, suggesting that the minor behavioral effects of BPA on radial arm 
maze performance in males may be due to other changes in brain anatomy or 
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functioning in the prefrontal cortex or the hippocampus.  The hippocampus is another 
structure which may mediate the minor behavior effects seen in males in radial arm 
maze behavior, given the overwhelming evidence that this brain area is integral for 
learning of spatial cognitive tasks. 
 Although only slight modifications in cognitive behavior were apparent with early 
exposure to BPA, there is evidence that BPA alters anxiety-related and social 
behaviors.  For example, many studies that have investigated the impact of BPA on 
these types of behaviors as assessed in open field and elevated plus maze (Patisaul & 
Bateman, 2008; Cox et al., 2010; Ryan & Vandenbergh, 2006; Adriani et al., 2003; 
Gioiosa et al., 2007; Rubin et al., 2006; Fujimoto et al., 2006; Kubo et al., 2001; 2003). 
These types of behavior are relevant to idea that BPA may induce changes that may 
increase the susceptibility for developmental neurological disorders, such as autism, 
schizophrenia, and ADHD.  In fact, several reviews have highlighted the potential for 
endocrine disruptors, such as BPA, to contribute these disorders (de Cock et al., 2012; 
Brown, 2009).  In conclusion, future studies are needed to determine whether the 
effects of BPA on different types of behavior and whether the neuron and glia changes 
demonstrated in the current study lead to behavioral changes that correspond to those 
seen in neurological disorders.  
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